TY - DATA T1 - Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging - Fig 2 PY - 2017/05/19 AU - Basma Ismail AU - Rob A. deKemp AU - Etienne Croteau AU - Tayebeh Hadizad AU - Kevin D. Burns AU - Rob S. Beanlands AU - Jean N. DaSilva UR - https://plos.figshare.com/articles/figure/Treatment_with_enalapril_and_not_diltiazem_ameliorated_progression_of_chronic_kidney_disease_in_rats_and_normalized_renal_AT_sub_1_sub_receptor_expression_as_measured_with_PET_imaging_-_Fig_2/5025449 DO - 10.1371/journal.pone.0177451.g002 L4 - https://ndownloader.figshare.com/files/8490584 KW - CKD KW - blood flow KW - calcium channel blockers KW - 1 R expression KW - kidney angiotensin II KW - diltiazem ameliorated progression KW - positron emission tomography KW - 1 R levels KW - 1 receptor expression KW - Nx KW - 1 R changes KW - PET imaging ACE inhibitors KW - kidney disease KW - enalapril KW - systolic blood pressure N2 - Body weight data obtained weekly over 10 weeks (A), terminal left kidney weight for sham (N = 8), Nx (N = 8), NxE (N = 6) and NxD (N = 8) (B) and heart weight for sham (N = 8), Nx (N = 9), NxE (N = 9) and NxD (N = 8) (C) normalized to body weight at 18–20 weeks post-surgery. Data are presented as mean±SD. * p<0.05 vs sham, $ p<0.05 vs Nx, # p<0.05 vs NxE (p<0.05). ER -